Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering with an automated solution for advanced discovery process Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing […]

PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collaboration with the NIH Intramural Center for Alzheimer’s and Related Dementias (NIH CARD) to build a more comprehensive single cell atlas of the human brain to further neuroscience research. Known for complementing a broad range of NIH-funded research that requires harnessing […]

Supports ambitious commercialisation strategy for DNA synthesis platform, gSynth Follows $10m Series A financing to scale operations   Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in […]

The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines, medicines, treatments, and therapies. Cambridge, UK  – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today […]

WASHINGTON, DC — Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”). The acquisition of Abcam for $24.00 per share in cash was implemented by way of a Court-sanctioned scheme of arrangement under the UK Companies Act 2006 (the “Scheme”) and the Scheme became effective in accordance with its terms […]

At the annual Nanopore Community Meeting in Houston, Oxford Nanopore will showcase progress in automation, integration and accessibility with end-to-end workflows.  Oxford Nanopore today announces the beta launch of its TurBOT sample-to-result device, developed in partnership with automation and manufacturing specialist Tecan, at its annual Nanopore Community Meeting in Houston. Beta access customers will receive […]

Company names Paul Davy as CEO, appoints David Summa as Executive Chairman of the Board MENLO PARK, Calif.–Ionpath, a pioneer in high-plex spatial proteomics, today announced that Paul Davy, former Vice President of Customer Experience, has been appointed CEO of the company. Outgoing CEO David Summa is now Executive Chairman of Ionpath’s Board of Directors. […]

● A reliable supply of consistent and physiologically relevant motor neurons is fundamental to the study and screening of potential treatments for motor neuron diseases (MNDs) ● ioMotor Neurons also offer an alternative to animals for neurotoxicity testing in the development of therapeutic products and consumer cosmetics procedures ● ioMotor Neurons are ready for experimentation […]

Omicsveu, a multiplex multiomics spatial biology company, proudly announces unveiling of an advanced spatial biology system. FREMOUNT, CALIFORNIA, USA — Omicsveu, a multiplex multiomics spatial biology company, proudly announces unveiling of an advanced spatial biology system. This innovative technology promises to accelerate Spatial Multiplex Multiomics research. The cornerstone of Omicsveu’s breakthrough lies in its spatial biology multiplex multiomics […]

Genomenon Curate-Pro Leverages Company’s Existing Infrastructure for Curating the Genome Genomenon, a leading genomic intelligence company, today announced the launch of Genomenon Curate-Pro, a rapid on-demand evidence curation and variant classification service for genetic testing labs. Genomenon Curate-Pro service leverages the company’s automation and genetic curation expertise to address the laborious and expensive variant research […]